Back to Journals » Research Reports in Clinical Cardiology » Volume 4

Transcatheter aortic valve replacement

Authors Damberg A, Benstoem C, Autschbach R, Goetzenich A

Received 17 April 2013

Accepted for publication 22 May 2013

Published 6 August 2013 Volume 2013:4 Pages 135—151


Checked for plagiarism Yes

Review by Single-blind

Peer reviewer comments 2

Anneke Damberg, Carina Benstoem, Ruediger Autschbach, Andreas Goetzenich

Department of Cardiovascular and Thoracic Surgery, University Clinic RWTH Aachen, Aachen, Germany

Abstract: The standard treatment for symptomatic severe aortic valve stenosis is surgical aortic valve replacement. Over the last decade, transcatheter aortic valve replacement has emerged as an option for patients judged inoperable. It might also constitute an alternative for high-risk patients, even though which patients might benefit from this approach is still being discussed and remains controversial. Transcatheter heart valve replacement is a rapidly spreading technology. However, a number of problems still need to be addressed, such as paravalvular regurgitation, stroke rate, and postoperative conduction disturbances. Further, the durability of transcatheter heart valves remains unclear. Randomized clinical trials and long-term follow-up will help define the role of transcatheter heart valve replacement in aortic stenosis therapy.

Keywords: TAVI, aortic valve replacement, transcatheter surgery

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]